Altered B-cell, plasma cell, and antibody immune profiles in blood of patients with systemic mastocytosis.

Autor: Pérez-Pons A; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Biomedical Research Networking Center Consortium, Madrid, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Henriques A; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo and Madrid, Spain., Contreras Sanfeliciano T; Department of Biochemistry, University Hospital of Salamanca, Salamanca, Spain., Jara-Acevedo M; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Biomedical Research Networking Center Consortium, Madrid, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Sequencing Service, University of Salamanca, Salamanca, Spain., Navarro-Navarro P; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Biomedical Research Networking Center Consortium, Madrid, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Sequencing Service, University of Salamanca, Salamanca, Spain., García-Montero AC; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Biomedical Research Networking Center Consortium, Madrid, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Álvarez-Twose I; Biomedical Research Networking Center Consortium, Madrid, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo and Madrid, Spain., Lecrevisse Q; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Biomedical Research Networking Center Consortium, Madrid, Spain., Fluxa R; Cytognos SL, Salamanca, Spain., Sánchez-Muñoz L; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo and Madrid, Spain., Caldas C; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Pozo J; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain., González-López Ó; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Pérez-Andrés M; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Biomedical Research Networking Center Consortium, Madrid, Spain., Mayado A; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Biomedical Research Networking Center Consortium, Madrid, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Orfao A; Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Biomedical Research Networking Center Consortium, Madrid, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain. Electronic address: orfao@usal.es.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.

Immune cell kinetics and antibody response in COVID-19 patients with low-count monoclonal B-cell lymphocytosis.

Autor: Oliva-Ariza G; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Fuentes-Herrero B; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Lecrevisse Q; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Carbonell C; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain., Pérez-Pons A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Torres-Valle A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Pozo J; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Martín-Oterino JÁ; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain., González-López Ó; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., López-Bernús A; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain.; Department of Infectious Diseases, University Hospital of Salamanca, Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain., Bernal-Ribes M; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Belhassen-García M; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain.; Department of Infectious Diseases, University Hospital of Salamanca, Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain., Pérez-Escurza O; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Pérez-Andrés M; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Vazquez L; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Pérez G; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain., García Palomo FJ; Spanish National DNA Bank Carlos III, NUCLEUS, University of Salamanca, Salamanca, Spain., Leoz P; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Costa-Alba P; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Emergency Department, University Hospital of Salamanca, Salamanca, Spain., Pérez-Losada E; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Intensive Care Department, University Hospital of Salamanca, Salamanca, Spain., Yeguas A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Santos Sánchez M; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., García-Blázquez M; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Morán-Plata FJ; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Damasceno D; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Botafogo V; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Muñoz-García N; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Fluxa R; Cytognos SL, Salamanca, Spain., van Dongen JJM; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Marcos M; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain., Almeida J; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Orfao A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC - University of Salamanca); Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: American journal of hematology [Am J Hematol] 2023 Dec; Vol. 98 (12), pp. 1909-1922. Date of Electronic Publication: 2023 Oct 04.

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients.

Autor: Oliva-Ariza G; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Fuentes-Herrero B; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Carbonell C; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain., Lecrevisse Q; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Infectious Diseases, University Hospital of Salamanca, Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain., Pérez-Pons A; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Torres-Valle A; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Pozo J; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Martín-Oterino JÁ; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain., González-López Ó; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., López-Bernús A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain.; Department of Infectious Diseases, University Hospital of Salamanca, Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain., Bernal-Ribes M; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Belhassen-García M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain.; Department of Infectious Diseases, University Hospital of Salamanca, Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain., Pérez-Escurza O; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Pérez-Andrés M; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Vazquez L; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Pérez G; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain., García Palomo FJ; Spanish National DNA Bank Carlos III, University of Salamanca, Salamanca, Spain., Leoz P; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Costa-Alba P; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Emergency Department, University Hospital of Salamanca, Salamanca, Spain., Pérez-Losada E; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Intensive Care department, University Hospital of Salamanca, Salamanca, Spain., Yeguas A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Santos Sánchez M; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., García-Blázquez M; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Morán-Plata FJ; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Damasceno D; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Botafogo V; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Muñoz-García N; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain., Fluxa R; Cytognos SL, Salamanca, Spain., Contreras-Sanfeliciano T; Department of Biochemistry, University Hospital of Salamanca, Salamanca, Spain., Almeida J; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Marcos M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain., Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLEUS), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Blood [Blood] 2023 Jan 19; Vol. 141 (3), pp. 309-314.

Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study.

Autor: Lhermitte L; Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris, Paris, France., Barreau S; Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris, Paris, France., Morf D; FACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland., Fernandez P; FACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland., Grigore G; Cytognos SL, Salamanca, Spain., Barrena S; Cytognos SL, Salamanca, Spain.; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., de Bie M; Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Flores-Montero J; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Brüggemann M; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Mejstrikova E; Department of Pediatric Hematology and Oncology, University Hospital Motol, Charles University, Prague, Czechia., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Burgos L; Applied Medical Research Center (CIMA), IDISNA, Clinica Universidad de Navarra (UNAV), Pamplona, Spain., Caetano J; Hemato-Oncology Laboratory, Portuguese Institute of Oncology, Lisbon, Portugal., Gaipa G; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza, MB, Italy., Buracchi C; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza, MB, Italy., da Costa ES; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Av. Horacio Macedo, Predio do CT, CEP, Rio de Janeiro, 21941-914, Brazil., Sedek L; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland., Szczepański T; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland., Aanei CM; Laboratory of Hematology, University Hospital of Saint-Etienne, Saint-Etienne, France., van der Sluijs-Gelling A; Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands., Delgado AH; Cytognos SL, Salamanca, Spain.; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Fluxa R; Cytognos SL, Salamanca, Spain., Lecrevisse Q; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Pedreira CE; Systems and Computing Department (PESC), COPPE, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil., van Dongen JJM; Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands., Orfao A; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., van der Velden VHJ; Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. v.h.j.vandervelden@erasmusmc.nl.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2021 Jan; Vol. 34 (1), pp. 59-69. Date of Electronic Publication: 2020 Sep 30.

Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study.

Autor: Verbeek MWC; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Rodríguez BS; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Sedek L; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Laqua A; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany., Buracchi C; Centro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Buysse M; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., Reiterová M; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Oliveira E; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Morf D; Institute for Laboratory Medicine, Aarau, Switzerland., Oude Alink SR; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Barrena S; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Kohlscheen S; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hofmans M; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., Fernandez P; Institute for Laboratory Medicine, Aarau, Switzerland., de Costa ES; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Mejstrikova E; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Szczepanski T; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Slota L; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Brüggemann M; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany., Gaipa G; Centro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Grigore G; Cytognos SL, Salamanca, Spain., van Dongen JJM; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Immunology, Leiden University Medical Center (LUMC), The Netherlands., Orfao A; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., van der Velden VHJ; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publikováno v: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Jul; Vol. 106 (4), pp. 252-263. Date of Electronic Publication: 2023 Sep 22.